SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What Is Metisl2 (METIS)? Metis: A Multi-Network Ecosystem Redefining Decentralized Infrastructure​ Metis is more than a Layer 2 - it is a multi-network ecosystem powered by the groundbreaking MetisSDK. Metis is building the future of decentralized infrastructure with a dual-network architecture: Andromeda for secure, general-purpose dApps and Hyperion for high-performance, AI-optimized execution. Both chains interoperate seamlessly, enabling builders to deploy scalable, efficient, and intelligent Web3 applications across sectors such as DeFi, gaming, DEPIN and AI.  What Is Andromeda ? Andromeda​​ serves as the foundational optimistic rollup network within the Metis ecosystem, delivering scalable decentralized infrastructure with Ethereum-level security and enhanced throughput. Optimized for DeFi, gaming, and general-purpose applications, it leverages a decentralized sequencer network and fraud-proof mechanisms to prioritize reliability and proven execution over extreme performance. Its battle-tested architecture supports a growing ecosystem of protocols requiring robust security models.  Andromeda will evolve alongside Hyperion, maintaining its core focus on secure general-purpose infrastructure. Key upgrades like on-chain data availability and fraud-proof refinements will advance its capabilities, with a roadmap targeting Stage 0 deployment soon and Stage 1 completion by year-end. As Metis’ cornerstone network, it remains the go-to solution for projects valuing decentralization (via full DSEQ nodes) and time-tested security frameworks.   What Is Hyperion ? Hyperion：The First Layer 2 Bringing On-Chain LLMs to Life Hyperion is a high-performance, AI-optimized Layer 2 solution designed to scale AI, DeFi, Depin and gaming applications. It enhances Metis' ecosystem by introducing parallel execution, AI-native infrastructure and decentralized sequencing, while maintaining Ethereum security and METIS as the gas token.  Hyperion, developed with the powerful MetisSDK and LazAI’s Alith AI framework, is the first Layer 2 Ethereum-compatible solution designed explicitly for on-chain AI execution, notably supporting Large Language Models (LLMs). It combines blockchain’s decentralized trust and transparency with AI's analytical and predictive powers, delivering an unparalleled user and developer experience.  This architecture optimizes the execution efficiency of AI processes within blockchain ecosystems, reducing computational overhead while maintaining network integrity. By embedding Alith’s modular framework for seamless AI/blockchain interoperability, Hyperion establishes a robust technical bridge between artificial intelligence and distributed ledger technologies.  This advancement fundamentally enhances decentralized application (dApp) capabilities, unlocking new possibilities for complex AI-driven functionalities in Web3 environments.  ✅ Key Features of Hyperion (HYPE):  Parallelized Transactions for Hyper-Scalability Hyperion’s Parallel Execution Engine, paired with an Optimistic Rollup model, processes multiple transactions simultaneously, delivering sub-second finality. Optimized fraud-proof mechanisms ensure security without sacrificing speed, making Hyperion perfect for real-time AI, gaming, and DeFi applications.  High Performance On-chain LLMS Inference By leveraging Rust's performance advantages and quick model inference technologies, Alith ensures that AI tasks in MetisSDK are executed efficiently, even under high transaction volumes. Revolutionizing Storage MetisDB eliminates storage bottlenecks with memory-mapped Merkle Trees, multi-version concurrency control, and asynchronous I/O processing. This ensures lightning-fast data access and cost-efficient state management, critical for data-intensive AI applications. AI-Optimized Powerhouse Hyperion’s Metis Virtual Machine (MetisVM) is custom-built for on-chain AI inference and high-throughput dApps. With dynamic opcode optimization, speculative parallel execution, and state-aware caching, MetisVM slashes gas fees and boosts processing speeds, enabling developers to run machine learning models directly on-chain. Seamless Ethereum and Cross-Chain Integration Hyperion commits state changes to Ethereum for battle-tested security while enabling cross-chain liquidity through a shared bridge framework. Integration with off-chain compute networks allows AI developers to leverage distributed processing power, creating scalable, interoperable dApps.  Why Choose Hyperion? Hyperion isn’t just another Layer 2 solution - it’s a revolutionary leap forward in how blockchain and AI interact. By placing high-performance, secure AI processes directly onto the blockchain, Hyperion reduces reliance on centralized systems, enhances transparency, and empowers developers and users alike.  This combination of scalability, efficiency, and high-performance inference positions Hyperion as the optimal choice for developers aiming to build next-generation decentralized applications.  The Hyperion Testnet Launch: Experience the Future Today Hyperion testnet launch invites AI developers, blockchain enthusiasts, Web3 developers, and tech innovators to explore, test, and innovate. Join us in pioneering a smarter, more intelligent blockchain ecosystem.  Hyperion is more than just an upgrade - it's the future of blockchain intelligence.  Access the Testnet: Visit https://hyperion.metis.io dive into Hyperion’s AI-optimized infrastructure. Explore Documentation: Find technical specs and developer resources at http://docs.metis.io/hyperion

Metis Token

Metis (METIS) is trending as an Ethereum Layer 2 solution, drawing significant attention for its advanced AI integration efforts, including its Hyperion L2 and MetisSDK for AI-native dApps. The community is actively discussing its potential for substantial price movement, frequently highlighting its low token supply and ongoing advancements in decentralized sequencers. Many in the community also note its unique connection to Ethereum's co-founder as a point of interest.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Trust - ProShares Ultra Silver

ProShares Ultra Silver ($AGQ) is a major talking point, fueled by strong community conviction around silver's critical industrial demand from AI and EV sectors, alongside impending Chinese export restrictions and persistent structural supply deficits. Many foresee a historic "silver squeeze" to rebalance its value against gold, with significant upside potential, though some traders remain cautious of market manipulation and short-term overbought conditions.

Bitwise 10 Crypto Index ETF - Common Shares Of Beneficial Interest

Bitwise 10 Crypto Index Fund

Bitwise 10 Crypto Index Fund is a focal point in a heated community debate over the imminent 'crypto winter,' with a vocal segment predicting a significant Bitcoin price correction based on historical 4-year cycles. This strong bearish outlook, often coupled with claims of market manipulation, contrasts with discussions around increasing institutional crypto adoption and Bitwise's active efforts to convert BITW to an ETP, which could address its persistent trading discount to net asset value.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is actively trending as it recently settled a key dispute in Mali, restoring operational control to its gold mines, and is evaluating an IPO for its North American gold assets to unlock value. The community is buzzing about these strategic moves, alongside the company's robust cash flow, increased dividends, and ongoing share buybacks. This comes amidst a broader bullish sentiment for precious metals, driven by rising gold prices and expectations for continued strength in the sector.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

OPGN is trending amid strong community optimism following recent SEC filings that signal progress toward NASDAQ relisting and highlight its strategic pivot to an AI-driven FinTech platform, CapForce. Investors are actively discussing this transformation from biotech to a high-growth financial sector, with many anticipating a substantial recovery backed by major shareholder AEI Capital, despite current low trading volume.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending due to the Trump administration's halt on offshore wind leases, including its Coastal Virginia project, sparking community debate over regulatory hurdles versus essential energy needs. Amidst this, significant discussion centers on Dominion's pivotal role in powering the burgeoning AI data center industry in Virginia, particularly with its exploration of Small Modular Reactors and recent partnerships. This creates a dual narrative for investors, weighing renewable energy's regulatory risks against substantial growth opportunities from increasing power demand.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending following promising preliminary Phase 3 open-label data indicating a significant reduction in breast cancer recurrence rates, which is driving substantial bullish sentiment. The community is actively discussing the therapy's expansive market potential and the strong confidence of insiders, fueling high anticipation for a potential short squeeze amidst extremely high borrow rates and a tight share float.

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Edgewise Therapeutics Inc

Edgewise Therapeutics is garnering significant attention following positive clinical updates for its EDG-7500 program in hypertrophic cardiomyopathy, demonstrating robust reductions in heart obstruction and a favorable safety profile without impacting ejection fraction. This potential differentiation from existing therapies is a key talking point within the community, fueling substantial trading volume and broad market interest. With ongoing pipeline advancements in both cardiac and muscular dystrophy treatments, institutional investors remain highly engaged.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending due to excitement over its Legend app launch and nearing max token supply, sparking hopes for a supply shock and potential fintech integrations within the DeFi sector. However, community discussion is sharply divided, with optimistic price targets contrasting with significant concerns about the protocol's financial runway and governance, often in comparison to rivals like AAVE.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill is trending amidst its recent authorization of a substantial share repurchase program and the upcoming launch of new high-protein menu items. The community is actively discussing whether these catalysts, alongside recent tariff rollbacks, can reignite traffic and overcome concerns about valuation and competition within the fast-casual dining sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Personalis (NASDAQ:PSNL) Sees Strong Trading Volume - Here's Why

Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Time to Buy...

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in Clinical Cancer Research, a journal of the American...

Personalis (NASDAQ:PSNL) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen upgraded Personalis from a "sell" rating to a "hold" rating in a report on Sunday...

Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Still a Buy?

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of one of the largest and most comprehensive patient cohorts to date from the...

Personalis (NASDAQ:PSNL) Stock Price Down 4.8% - What's Next?

Personalis (NASDAQ:PSNL) Trading Down 4.8% - Here's Why...

Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded Personalis from a "hold" rating to a "sell" rating in a research note on Saturday...

Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL

Geode Capital Management LLC lifted its position in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 165.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The...

Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling

Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling...

Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages

Personalis, Inc. (NASDAQ:PSNL - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. One...

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Current Price	$8.41
Prev Close	$8.42
Open	$8.44
Dividend Yield	0.00%
50-Day Moving Average	$9.00
Beta	2.22
Avg. Volume	1.85M
PE Ratio	-9.60

52-Week High	$11.40
52-Week Low	$2.83
Market Capitalization	$747.73M
EPS (Annual)	-$1.37
Price to Book	4.35
Revenue Per Employee	$369,493.45
Enterprise Value/EBITDA	N/A

PSNL
Personalis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PSNL News

PSNLPersonalis Inc